To the content
2 . 2014

Hard-to-treat patient with hepatitis C – what will change with interferon-free therapy?

AbstractThe article explores current and future approaches to the management of hard-to-treat patients with chronic HCV infection. Specific features of hard-totreat patients are reviewed in the context of upcoming implementation of IFN-free regimens. Recently published data resulted from completed IFN-free regimens’ studies is presented and discussed with a special focus on traditionally hard-to-treat populations including patients with: previous virological failures, non-CC IL-28B genotype, high viral load, metabolic disorders, progressed fibrosis or cirrhosis and finally – liver transplant patients.

Keywords:hard-to-treat patients, HCV, treatment, IFN-free regimens

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)

Journals of «GEOTAR-Media»